Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in Mice
ABSTRACT Recently, probiotics have been widely used as an adjuvant therapy to cure, prevent, or improve certain diseases. However, no research has been carried out into the dose of probiotics, especially the maximum dose. Therefore, the effective and safe dosage of probiotics needs to be studied. Re...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2021-12-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.01847-21 |
| _version_ | 1818973878569926656 |
|---|---|
| author | Pengcheng Lou Yangfan Shen Aoxiang Zhuge Longxian Lv Xueling Zhu Yin Yuan Liya Yang Kaicen Wang Bo Li Lanjuan Li |
| author_facet | Pengcheng Lou Yangfan Shen Aoxiang Zhuge Longxian Lv Xueling Zhu Yin Yuan Liya Yang Kaicen Wang Bo Li Lanjuan Li |
| author_sort | Pengcheng Lou |
| collection | DOAJ |
| description | ABSTRACT Recently, probiotics have been widely used as an adjuvant therapy to cure, prevent, or improve certain diseases. However, no research has been carried out into the dose of probiotics, especially the maximum dose. Therefore, the effective and safe dosage of probiotics needs to be studied. Recently, L. Yang, X. Bian, W. Wu, L. Lv, et al. (Microb Biotechnol 13:1860–1876, 2020, https://doi.org/10.1111/1751-7915.13629) discovered that Lactobacillus salivarius Li01 had a protective effect on thioacetamide-induced acute liver injury and hyperammonemia, and a fixed concentration (3 × 109 CFU/mL) of L. salivarius Li01 was applied in their study. However, the most effective treatment concentration of L. salivarius Li01 remains unknown. Therefore, four concentration gradients of L. salivarius Li01 suspension were prepared for groups of mice to have different levels of bacterial colonization by gavage. Then, acute liver injury and hyperammonemia were induced via thioacetamide administration. By observation and detection, an inverted U-shaped protective effect from L. salivarius Li01 existed in thioacetamide-induced acute liver injury and hyperammonemia. Of note, significant deterioration was confirmed within the group that was orally administered with an excessive concentration of L. salivarius Li01 suspension, and this was attributed to endotoxemia that resulted from compromised immunity, a damaged intestinal barrier, and bacterial translocation. IMPORTANCE This research investigated the relationship between the concentration of Lactobacillus salivarius Li01 and its impact on mice that had a thioacetamide-induced acute liver injury and hyperammonemia. These findings could provide new insights into the effective, proper, and safe use of probiotics. |
| first_indexed | 2024-12-20T15:31:10Z |
| format | Article |
| id | doaj.art-0ad2600c26834692b6a36e95e1ed7298 |
| institution | Directory Open Access Journal |
| issn | 2165-0497 |
| language | English |
| last_indexed | 2024-12-20T15:31:10Z |
| publishDate | 2021-12-01 |
| publisher | American Society for Microbiology |
| record_format | Article |
| series | Microbiology Spectrum |
| spelling | doaj.art-0ad2600c26834692b6a36e95e1ed72982022-12-21T19:35:36ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972021-12-019310.1128/spectrum.01847-21Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in MicePengcheng Lou0Yangfan Shen1Aoxiang Zhuge2Longxian Lv3Xueling Zhu4Yin Yuan5Liya Yang6Kaicen Wang7Bo Li8Lanjuan Li9State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaABSTRACT Recently, probiotics have been widely used as an adjuvant therapy to cure, prevent, or improve certain diseases. However, no research has been carried out into the dose of probiotics, especially the maximum dose. Therefore, the effective and safe dosage of probiotics needs to be studied. Recently, L. Yang, X. Bian, W. Wu, L. Lv, et al. (Microb Biotechnol 13:1860–1876, 2020, https://doi.org/10.1111/1751-7915.13629) discovered that Lactobacillus salivarius Li01 had a protective effect on thioacetamide-induced acute liver injury and hyperammonemia, and a fixed concentration (3 × 109 CFU/mL) of L. salivarius Li01 was applied in their study. However, the most effective treatment concentration of L. salivarius Li01 remains unknown. Therefore, four concentration gradients of L. salivarius Li01 suspension were prepared for groups of mice to have different levels of bacterial colonization by gavage. Then, acute liver injury and hyperammonemia were induced via thioacetamide administration. By observation and detection, an inverted U-shaped protective effect from L. salivarius Li01 existed in thioacetamide-induced acute liver injury and hyperammonemia. Of note, significant deterioration was confirmed within the group that was orally administered with an excessive concentration of L. salivarius Li01 suspension, and this was attributed to endotoxemia that resulted from compromised immunity, a damaged intestinal barrier, and bacterial translocation. IMPORTANCE This research investigated the relationship between the concentration of Lactobacillus salivarius Li01 and its impact on mice that had a thioacetamide-induced acute liver injury and hyperammonemia. These findings could provide new insights into the effective, proper, and safe use of probiotics.https://journals.asm.org/doi/10.1128/spectrum.01847-21Lactobacillus salivariusprobioticacute liver failurehyperammonemiathioacetamide |
| spellingShingle | Pengcheng Lou Yangfan Shen Aoxiang Zhuge Longxian Lv Xueling Zhu Yin Yuan Liya Yang Kaicen Wang Bo Li Lanjuan Li Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in Mice Microbiology Spectrum Lactobacillus salivarius probiotic acute liver failure hyperammonemia thioacetamide |
| title | Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in Mice |
| title_full | Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in Mice |
| title_fullStr | Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in Mice |
| title_full_unstemmed | Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in Mice |
| title_short | Dose-Dependent Relationship between Protection of Thioacetamide-Induced Acute Liver Injury and Hyperammonemia and Concentration of Lactobacillus salivarius Li01 in Mice |
| title_sort | dose dependent relationship between protection of thioacetamide induced acute liver injury and hyperammonemia and concentration of lactobacillus salivarius li01 in mice |
| topic | Lactobacillus salivarius probiotic acute liver failure hyperammonemia thioacetamide |
| url | https://journals.asm.org/doi/10.1128/spectrum.01847-21 |
| work_keys_str_mv | AT pengchenglou dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT yangfanshen dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT aoxiangzhuge dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT longxianlv dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT xuelingzhu dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT yinyuan dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT liyayang dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT kaicenwang dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT boli dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice AT lanjuanli dosedependentrelationshipbetweenprotectionofthioacetamideinducedacuteliverinjuryandhyperammonemiaandconcentrationoflactobacillussalivariusli01inmice |